Hamilton Lane reports fiscal Q4 results after the close today, entering the print after a bruising month that has left the stock down 16% to $85.16 — well below where analysts have been setting their sights.
The most telling signal heading into tonight is the gap between where analysts have HLNE valued and where the market has priced it. JP Morgan's Kenneth Worthington cut his target to $148 yesterday — maintaining an Overweight rating — but even that trimmed figure sits 74% above the current price. Morgan Stanley holds at Equal-Weight with a $141 target, while Oppenheimer kept its Outperform but slashed the target from $230 to $171 in April. The direction of travel has been uniform: every major desk has moved targets lower since February, though none have abandoned their constructive ratings. That combination — still-bullish ratings, sharply reduced targets — reflects a Street that believes in the private markets story but has become more cautious on near-term execution and valuation.
The bull case rests on evergreen platform growth. Fee-paying AUM on that platform reached $12.5 billion, up roughly 65% year-over-year, and forward revenue estimates for fiscal years 2026 and 2027 carry meaningful upgrades. Bears point to a slight deceleration in capital raising — $3.4 billion last quarter, down from $3.5 billion previously — and argue that limited transparency around product structures makes it harder for outside investors to underwrite the growth trajectory. The valuation has compressed materially: the forward P/E multiple has dropped roughly 3.6 points over the past 30 days, now running at 12.9x, while price-to-book has shed nearly 0.7 turns to 2.8x. EPS momentum, however, ranks in the 79th percentile on a 90-day basis, suggesting the fundamental estimate trend has not broken down.
The peer group confirms this is a sector-wide reset, not just an HLNE story. StepStone fell 3.9% on the week, Carlyle dropped 5.2%, TPG was off 6.3%, and Blue Owl led the group lower at -10.4%. HLNE's 4.3% weekly decline sits roughly in line with the peer median, which suggests the drawdown reflects broader private markets sentiment rather than company-specific pressure.
Short interest and the options market both read as measured rather than aggressive. Short interest has grown about 9% over the past month to 8.9% of the float — not trivial, but with borrow costs running at just 0.41% and availability at 527%, there is no meaningful squeeze tension in the lending market. The put/call ratio at 0.59 is modestly above its 20-day average, a shade more defensive than neutral, but well off the 52-week high of 1.46.
What tonight's print will test is whether the evergreen platform's asset growth is converting into the fee revenue acceleration the bulls have pencilled in — and whether capital-raising momentum can hold even as the broader private markets fundraising environment has softened.
See the live data behind this article on ORTEX.
Open HLNE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
